Advinus is a R&D services company that supports the discovery and development of compounds for diverse industries including Pharmaceuticals, Biologicals, Agrochemicals, Nutraceuticals and Cosmetics. Advinus is promoted by the Tata Group, the largest conglomerate from India having a group turnover of approximately USD 110 billion.
The Company’s Development center located in Bangalore has over 24 years of GLP experience in conducting regulatory studies in compliance with global regulations for supporting clinical trials and registration of substances and products globally. For the pharma/biotech industries, Advinus offers end-to-end services in the areas of preclinical toxicology testing, chemical process development, analytical R&D, drug metabolism and pharmacokinetics for IND submission. In addition, the company also offers long term non-clinical toxicology testing, including carcinogenicity studies, in support of pharmaceutical new drug applications (NDA). Advinus also supports various analytical, toxicology, chemistry services for regulatory submission requirements of other industries such as Agrochemicals, Cosmetics, Nutraceuticals, and Industrial Chemical.
Advinus is also one of the pioneers in drug discovery services in India, with a track record that is well demonstrated by its path breaking collaborations with the likes of Takeda, Merck, J&J, Novartis, Celgene and DNDi. Advinus’ Discovery center, established in 2006, is based out of Pune and offers drug discovery services including medicinal chemistry, discovery biology and ADMET.